Multi-Cancer Early Detection 101
- Non-member - Free!
- Member - Free!
This webinar is open to the public. You do not need to be an ACCC member to view this webinar, but you will need to create an account in order to register.
If You DO NOT Have an ACCC Account:
- To start, click the green “Register” button in the upper right corner of this page. You will be directed to “Your Cart.” Click the green “Log In” button near the top of the page.
- ACCC and State Society Members: Click “Reset Password” to update your login information. When your password is updated, you will be redirected to the “My Profile” page.
- Non-members: Click “Create Account.” Once your password is created, you will be redirected to the "My Profile" page.
- Click “eLearning” at the top of your profile page to go back to the ACCC eLearning portal. In the box on the left side of the screen, click on the “Cart” link.
- The green box in the upper right corner of this page will indicate “You are registered!” for this course!
If You Have an ACCC Account:
- Please click the orange “Log In” button on the left side of this screen. You will be taken to the main login page that displays your email and password. Click the “Log in” button.
- You will be automatically redirected back to webinar page, and the green box in the upper right corner will say that “You are registered!” for this course!
PRO TIP: If you save your ACCC password to your computer and remain logged in, you can register for additional webinars and courses in a matter of seconds—with just one click!
For the best registration and viewing experience, please use Chrome, Edge, or Safari web browsers. Internet Explorer users may experience difficulties accessing the webinar.
Once you complete your registration, you will receive an email from ACCC eLearning, which contains information on how to access this webinar. For assistance with registration or if you do not receive an email, please contact email@example.com.
Multi-Cancer Early Detection (MCED) 101
Advancements in blood-based multi-cancer early detection screening platforms are on the horizon, bringing the latest advances in cancer screening technologies to patients and healthcare providers. Thought leader, Chetan Bettegowda, shares insights with the multidisciplinary team and addresses questions related to their experiences with MCED in real time.
Chetan Bettegowda, MD, PHD
Associate Professor, Department of Neurosurgery and Oncology
Johns Hopkins University School of Medicine
This project is sponsored by Exact Sciences.
This webinar is open to the public. You do not need to be an ACCC member to view this webinar, but you will need to create an account to register. Please click the "Registration Instructions" tab for details.
Chetan Bettegowda, MD, PhD
Associate Professor in the Department of Neurosurgery and Oncology
Johns Hopkins University School of Medicine
Chetan Bettegowda attended Duke University as a Benjamin N. Duke Scholar, where he graduated with a double major in Biology and Religion. He went on to complete his MD and PhD degree in Cellular and Molecular Medicine at the Johns Hopkins University School of Medicine, in the laboratory of Drs. Bert Vogelstein and Ken Kinzler. After finishing the MD/PhD program, Dr. Bettegowda completed his neurosurgery training at Johns Hopkins. While a resident, he returned to the Vogelstein/Kinzler lab to finish a post-doctoral fellowship.
Dr. Bettegowda is currently the Jennison and Novak Families Professor of Neurosurgery and Oncology and Vice Chair for Research in the Department of Neurosurgery at the Johns Hopkins University School of Medicine. His clinical focus is on the surgical management of brain tumors, while studying the molecular events cause them to arise in the laboratory. In particular, his current research is focused on translating our genetic understanding of tumors for diagnostic benefit. As Medical Director of the Ludwig Center for Cancer Genetics and Therapeutics, his efforts have focused on the applications of cell free tumor derived DNA for the early detection and monitoring of a myriad of cancers. His research is funded by the Burroughs Wellcome Career Award for Medical Scientists, Doris Duke Clinician Scientist Award, Department of Defense and the National Cancer Institute. He has been recognized with numerous awards including being named the William Baumgartner Johns Hopkins Physician of the Year. He has published widely with over 230 articles including in journals such as Science, Science Translational Medicine, Nature Genetics, Nature Communications and PNAS.